What we learnt from Cochlear, Wesptac, Ampol and Bendigo’s results - (ASX:COH)

Market Cap (16-May) $17,577,406,464 (45th)	Close (30-Jun) $229.07 -0.54000000000002 (-0.24%)	Volume (30-Jun) 181,871	Shortsold (5-May) 481,774 (0.74%) (261st)
52w High $345.00	52w Low $246.14	P/E 38.17	EPS 5.64

[ARTICLE] What we learnt from Cochlear, Wesptac, Ampol and Bendigo’s results

MediaBot

February 19, 2024 16:17

A news article has been posted about Cochlear on the AFR. The article was published around February 19, 2024 16:17, on 19 February 2024 at 4:17pm.

Cochlear’s reason for stopping its buyback was surprise, while Westpac is looking stable, Ampol’s Matt Halliday is keeping his powder dry and competition hits Bendigo and Adelaide Bank.

Read Article

COH was $229.07 at the close of trade on 30 June 2023

Recent Articles about ASX:COH
14-Apr	‘Could be next Cochlear or ResMed’: heart device maker wins FDA approval afr.com
14-Feb	Cochlear says US cost-of-living pressures hit services revenue afr.com
31-Dec	David Kent Honoured For Services To Deaf And Hard Of Hearing Community scoop.co.nz
30-Dec	Whitehall and officer accused in death of man with disabilities respond to allegations msn.com
30-Dec	Sensorion completes enrollment of the first cohort of the Audiogene phase 1/2 gene therapy clinical trial pharmabiz.com
30-Dec	3D printed microneedles used to treat hearing loss voxelmatters.com
29-Dec	Mumbai: KEM Hospital's Cochlear Implant Programme Transforms Lives Of 650 Hearing-Impaired Children msn.com
28-Dec	Iowans are 'Hearing' again thanks to the UIHC Cochlear Implant Program and decades of research kwwl.com
27-Dec	Sensorion Announces Completion of Enrollment of The First Cohort of The Audiogene Phase 1/2 Gene Therapy Clinical Trial businesswire.com
27-Dec	Otoacoustic emissions but not behavioral measurements predict cochlear-nerve frequency tuning in an avian vocal-communication specialist elifesciences.org
Tracked

Find all articles about Cochlear, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

End of Day Prices

Date	Close	Volume	Change
14-May	$264.93	130,038	-0.87 (0.33%)
12-May	$265.80	133,402	+0.12 (0.05%)
08-May	$265.68	139,631	-0.38 (0.14%)
07-May	$266.06	168,088	-3.31 (1.23%)
05-May	$269.37	109,503	-6.12 (2.22%)
02-May	$275.49	125,300	+1.89 (0.69%)
01-May	$273.60	144,576	-0.99 (0.36%)
30-Apr	$274.59	296,511	+6.18 (2.30%)
28-Apr	$268.41	163,558	+3.79 (1.43%)
24-Apr	$264.62	149,093	+3.62 (1.39%)
17-Apr	$261.00	235,981	+1.70 (0.66%)
16-Apr	$259.30	121,530	-1.70 (0.65%)
14-Apr	$261.00	248,716	+10.42 (4.16%)
11-Apr	$250.58	197,227	-5.78 (2.25%)
08-Apr	$256.36	314,181	+3.03 (1.20%)
8 up, 7 down, and 0 flat days

High $229.15	Low $226.18	Trades 9,945	Turnover $41,610,921	Volume 181,871
30 June 2023 at 4:12pm

High $229.15	Low $226.18	Trades 9,945	Turnover $41,610,921	Volume 181,871
30 June 2023 at 4:12pm

Cochlear Health Care
Africa Hearing Medical

$229.07 -0.54 (-0.24%)

COCHLEAR LIMITED Health Care Equipment & Services

[ARTICLE] What we learnt from Cochlear, Wesptac, Ampol and Bendigo’s results

MediaBot

$229.07 -0.54 (-0.24%)

Followers

Prices

Announcements

End of Day Prices

Cochlear Health Care Africa Hearing Medical

$229.07 -0.54 (-0.24%)

COH COCHLEAR LIMITED Health Care Equipment & Services

[ARTICLE] What we learnt from Cochlear, Wesptac, Ampol and Bendigo’s results

MediaBot

$229.07 -0.54 (-0.24%)

Followers

Prices

Announcements

End of Day Prices

Cochlear Health Care
Africa Hearing Medical

COCHLEAR LIMITED Health Care Equipment & Services